1.Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA: Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation 2019, 16:142.
2.Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Roman L, Serena J, Abilleira S, Ribo M, et al: Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015, 372:2296–2306.
3.Campbell BCV, Ma H, Ringleb PA, Parsons MW, Churilov L, Bendszus M, Levi CR, Hsu C, Kleinig TJ, Fatar M, et al: Extending thrombolysis to 4.5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet 2019, 394:139–147.
4.Jickling GC, Dziedzic T: Neutrophil count is related to stroke outcome following endovascular therapy. Neurology 2019, 93:194–195.
5.Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR: Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab 2015, 35:888–901.
6.Tang C, Wang C, Zhang Y, Xue L, Li Y, Ju C, Zhang C: Recognition, Intervention, and Monitoring of Neutrophils in Acute Ischemic Stroke. Nano Lett 2019, 19:4470–4477.
7.Cuartero MI, Ballesteros I, Moraga A, Nombela F, Vivancos J, Hamilton JA, Corbi AL, Lizasoain I, Moro MA: N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARgamma agonist rosiglitazone. Stroke 2013, 44:3498–3508.
8.Certo M, Endo Y, Ohta K, Sakurada S, Bagetta G, Amantea D: Activation of RXR/PPARgamma underlies neuroprotection by bexarotene in ischemic stroke. Pharmacol Res 2015, 102:298–307.
9.Garcia-Culebras A, Duran-Laforet V, Pena-Martinez C, Moraga A, Ballesteros I, Cuartero MI, de la Parra J, Palma-Tortosa S, Hidalgo A, Corbi AL, et al: Role of TLR4 (Toll-Like Receptor 4) in N1/N2 Neutrophil Programming After Stroke. Stroke 2019:STROKEAHA119025085.
10.Wang X, Chen S, Ni J, Cheng J, Jia J, Zhen X: miRNA–3473b contributes to neuroinflammation following cerebral ischemia. Cell Death Dis 2018, 9:11.
11.Sonoda T, Matsuzaki J, Yamamoto Y, Sakurai T, Aoki Y, Takizawa S, Niida S, Ochiya T: Serum MicroRNA-Based Risk Prediction for Stroke. Stroke 2019, 50:1510–1518.
12.Eyileten C, Wicik Z, De Rosa S, Mirowska-Guzel D, Soplinska A, Indolfi C, Jastrzebska-Kurkowska I, Czlonkowska A, Postula M: MicroRNAs as Diagnostic and Prognostic Biomarkers in Ischemic Stroke-A Comprehensive Review and Bioinformatic Analysis. Cells 2018, 7.
13.Zhao H, Li G, Wang R, Tao Z, Ma Q, Zhang S, Han Z, Yan F, Li F, Liu P, et al: Silence of miR–494 impairs neurotoxic Th1 shift via regulating STAT4-STAT4 cascade in ischemic stroke. Br J Pharmacol 2019.
14.Han Z, Zhao H, Tao Z, Wang R, Fan Z, Luo Y, Luo Y, Ji X: TOPK Promotes Microglia/Macrophage Polarization towards M2 Phenotype via Inhibition of HDAC1 and HDAC2 Activity after Transient Cerebral Ischemia. Aging Dis 2018, 9:235–248.
15.Venosa A, Gow JG, Hall L, Malaviya R, Gow AJ, Laskin JD, Laskin DL: Regulation of Nitrogen Mustard-Induced Lung Macrophage Activation by Valproic Acid, a Histone Deacetylase Inhibitor. Toxicol Sci 2017, 157:222–234.
16.McGrath JC, Lilley E: Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 2015, 172:3189–3193.
17.Zhao H, Li G, Wang R, Tao Z, Zhang S, Li F, Han Z, Li L, Liu P, Luo Y: MiR–424 prevents astrogliosis after cerebral ischemia/reperfusion in elderly mice by enhancing repressive H3K27me3 via NFIA/DNMT1 signaling. FEBS J 2019.
18.Deng Y, Herbert JA, Smith CM, Smyth RL: An in vitro transepithelial migration assay to evaluate the role of neutrophils in Respiratory Syncytial Virus (RSV) induced epithelial damage. Sci Rep 2018, 8:6777.
19.Mizuno R, Kawada K, Itatani Y, Ogawa R, Kiyasu Y, Sakai Y: The Role of Tumor-Associated Neutrophils in Colorectal Cancer. Int J Mol Sci 2019, 20.
20.Shin Y, Ghate NB, Moon B, Park K, Lu W, An W: DNMT and HDAC inhibitors modulate MMP–9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis. Epigenetics Chromatin 2019, 12:25.
21.Xiong C, Guan Y, Zhou X, Liu L, Zhuang MA, Zhang W, Zhang Y, Masucci MV, Bayliss G, Zhao TC, Zhuang S: Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis. FASEB J 2019, 33:8249–8262.
22.Moores RC, Brilha S, Schutgens F, Elkington PT, Friedland JS: Epigenetic Regulation of Matrix Metalloproteinase–1 and –3 Expression in Mycobacterium tuberculosis Infection. Front Immunol 2017, 8:602.
23.Ma H, Qi MY, Zhang X, Zhang YL, Wang L, Li ZQ, Fu B, Wang WT, Liu D: HSPC117 is regulated by epigenetic modification and is involved in the migration of JEG–3 cells. Int J Mol Sci 2014, 15:10936–10949.
24.Swingler TE, Kevorkian L, Culley KL, Illman SA, Young DA, Parker AE, Lohi J, Clark IM: MMP28 gene expression is regulated by Sp1 transcription factor acetylation. Biochem J 2010, 427:391–400.
25.Gao C, Cheng X, Lam M, Liu Y, Liu Q, Chang KS, Kao HY: Signal-dependent regulation of transcription by histone deacetylase 7 involves recruitment to promyelocytic leukemia protein nuclear bodies. Mol Biol Cell 2008, 19:3020–3027.
26.Feigenson M, Shull LC, Taylor EL, Camilleri ET, Riester SM, van Wijnen AJ, Bradley EW, Westendorf JJ: Histone Deacetylase 3 Deletion in Mesenchymal Progenitor Cells Hinders Long Bone Development. J Bone Miner Res 2017, 32:2453–2465.
27.Zeidan-Chulia F, Yilmaz D, Hakkinen L, Kononen E, Neves de Oliveira BH, Guncu G, Uitto VJ, Caglayan F, Gursoy UK: Matrix metalloproteinase–7 in periodontitis with type 2 diabetes mellitus. J Periodontal Res 2018, 53:916–923.
28.Gill SE, Nadler ST, Li Q, Frevert CW, Park PW, Chen P, Parks WC: Shedding of Syndecan–1/CXCL1 Complexes by Matrix Metalloproteinase 7 Functions as an Epithelial Checkpoint of Neutrophil Activation. Am J Respir Cell Mol Biol 2016, 55:243–251.
29.Ma F, Martinez-San Segundo P, Barcelo V, Morancho A, Gabriel-Salazar M, Giralt D, Montaner J, Rosell A: Matrix metalloproteinase–13 participates in neuroprotection and neurorepair after cerebral ischemia in mice. Neurobiol Dis 2016, 91:236–246.
30.Lin C, Lin W, Yeh S, Li L, Chang C: Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals. Oncotarget 2015, 6:43081–43089.
31.Lenglet S, Montecucco F, Mach F, Schaller K, Gasche Y, Copin JC: Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. Thromb Haemost 2014, 112:363–378.
32.Purroy A, Roncal C, Orbe J, Meilhac O, Belzunce M, Zalba G, Villa-Bellosta R, Andres V, Parks WC, Paramo JA, Rodriguez JA: Matrix metalloproteinase–10 deficiency delays atherosclerosis progression and plaque calcification. Atherosclerosis 2018, 278:124–134.
33.Bakhashab S, Ahmed F, Schulten HJ, Ahmed FW, Glanville M, Al-Qahtani MH, Weaver JU: Proangiogenic Effect of Metformin in Endothelial Cells Is via Upregulation of VEGFR1/2 and Their Signaling under Hyperglycemia-Hypoxia. Int J Mol Sci 2018, 19.
34.Zhao H, Li G, Zhang S, Li F, Wang R, Tao Z, Ma Q, Han Z, Yan F, Fan J, et al: Inhibition of histone deacetylase 3 by MiR–494 alleviates neuronal loss and improves neurological recovery in experimental stroke. J Cereb Blood Flow Metab 2019:271678X19875201.